last posts

Global Research Antibodies Market Report 2022: Rising Partnerships and Collaborations Fuel Industry Growth - ResearchAndMarkets.com

techsm5

DUBLIN–(BUSINESS WIRE)–The “Research Antibodies Market Report, By Product Type, By Form, By Source, By Application, By End-User, And By Region – Size, Share, Outlook, and Opportunity Analysis, 2022- 2030″ has been added to from ResearchAndMarkets.com offer.

Small proteins known as antibodies, which are an essential component of the immune system’s response to disease, are useful in biomedical research. For decades, researchers have been developing antibodies to fight and understand viruses like Covid-19 and many common infectious disorders. The majority of antibodies used in research are said to be of animal origin and are obtained from animals. A small amount of the desired foreign antigen is injected into an animal. This triggers the immune system to generate defense antibodies. These are then collected for use in research, either from the spleen or blood.

Market dynamics

Increasing collaborations and partnerships among market players are expected to contribute to significant growth over the forecast period. For example, in March 2022, Sanofi, a French multinational pharmaceutical and healthcare company, and Seagen Inc., an American biotechnology company, announced an exclusive collaboration agreement to design, develop and commercialize antibody-drug conjugates (ADCs) for up to to three cancer targets. .

The collaboration will use Sanofi’s proprietary monoclonal antibody (mAb) technology and Seagen’s proprietary ADC technology. Sanofi is currently working on an ADC, which is an antibody designed to carry powerful anti-cancer drugs to tumor cells expressing a certain protein.

Rising product launches by market players are expected to drive the growth of the global research antibody market over the forecast period. For example, in April 2019, ImmunoPrecise, a full-service therapeutic antibody discovery company, launched DeepDisplay, an antibody discovery platform with an unknown US pharmaceutical company.

Unlike conventional technologies, DeepDisplay uses immunization of transgenic animals combined with phage display antibody selection to deliver the most therapeutically relevant antibodies in the shortest possible time with the best chance of success.

Rising product approvals are expected to drive the market growth over the forecast period. For example, in April 2021, Gilead Sciences Inc., an American biopharmaceutical company, announced that Trodelvy (sacituzumab govitecan-hziy), for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, received full US Food and Drug Administration (FDA) approval. Trodelvy (sacituzumab govitecan-hziy) is an antibody-drug conjugate that combines a humanized monoclonal antibody.

Main characteristics of the study:

  • This report provides an in-depth analysis of the global research antibody market, market size (Million US$) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the reference year.

  • It elucidates potential revenue opportunities in different segments and explains an attractive investment proposition matrix for this market.

  • This study also provides key insights into the market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players.

  • It features leading players in the global Research Antibodies market based on the following parameters: company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.

  • Key companies covered in this study include Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signaling Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies , Danaher Corporation, BioLegend Inc., Illumina, Phoenix Pharmaceuticals and Abcam plc.

  • The information in this report would enable marketers and managing authorities of companies to make an informed decision regarding their future product launch, technology upgrade, market expansion and marketing tactics.

  • The Global Research Antibodies Market report is targeted at various stakeholders of this industry including investors, suppliers, manufacturers, distributors, new entrants and financial analysts.

  • Stakeholders would have an ease in making decisions through various strategic matrices used to analyze the global Research Antibodies market

Detailed segmentation:

Global Research Antibodies Market, By Product Type:

  • Primary antibodies

  • Secondary antibodies

  • Reagents

  • Consumables

Global Research Antibodies Market, By Form:

  • Monoclonal antibodies

  • Polyclonal antibodies

  • Recombinant antibodies

Global Research Antibodies Market, By Source:

  • Mouse

  • Rabbit

  • Goat

  • Others (Guinea Pigs, Rat etc.)

Global Research Antibodies Market, By Application:

  • Western blot

  • ELISA

  • Flow cytometry

  • Immunocytochemistry (ICC)/ Immunofluorescence (IF)

  • Immunohistochemistry (IHC)

  • Others (Immunoprecipitation, Multiplex Immunosorbent Assay and etc.)

Global Research Antibodies Market, By End User:

  • Academic and research institutes

  • Contract research organizations

  • Pharmaceutical and biotechnology companies

Company Profiles

  • Thermo Fisher Scientific Inc.

  • Bio-rad Laboratories

  • Lonza Group

  • Merck Millipore

  • Cell Signaling Technology Inc.

  • F.Hoffmann La Roche Ltd.

  • Novartis AG

  • Takeda Pharmaceutical Company

  • AgilentTechnologies

  • Danaher Corporation

  • BioLegend Inc.

  • Illuminated

  • Pharmaceutical Phoenixes

  • Abcam plc.

Main topics covered:

1. Research objectives and hypotheses

2. Market Overview

3. Market dynamics, regulation and trend analysis

4. Global Research Antibodies Market- Impact of the Coronavirus (Covid-19) Pandemic

5. Global Research Antibodies Market, by Product Type, 2017-2030 (USD Million)

6. Global Research Antibodies Market, By Form, 2017-2030 (USD Million)

7. Global Research Antibodies Market, by Source, 2017-2030 (USD Million)

8. Global Research Antibodies Market, by Application, 2017-2030 (USD Million)

9. Global research antibodies market, by end-user, 2017-2030 (USD Million)

10. Global Research Antibodies Market, by Region, 2017-2030 (USD Million)

11. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/621cr6

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

techsm5

Comments



Font Size
+
16
-
lines height
+
2
-